𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized controlled trial of adenine arabinoside 5′-phosphate in chronic active hepatitis B: Comparison of the efficacy of the treatment in heterosexual and homosexual patients

Book ID
123216754
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
81 KB
Volume
5
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized controlled trial of adenine a
Randomized controlled trial of adenine arabinoside 5′-monophosphate in chronic active hepatitis B: Comparison of the efficacy in heterosexual and homosexual patients
✍ Patrick Marcellin; Denis Ouzan; Françoise Degos; Christian Brechot; Etienne-Henr 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 1 views

Twenty-two heterosexuals and 2 1 homosexuals with chronic active hepatitis B and who had HBsAg, HBeAg and hepatitis B virus DNA in serum were randomized separately to receive adenine arabinoside monophosphate or placebo. In the 10 heterosexuals and nine homosexuals who received placebo, no change in

Efficacy of thymosin α1 in patients with
Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial
✍ Rong-Nan Chien; Yun-Fan Liaw; Tse-Ching Chen; Chau-Ting Yeh; I.-Shyan Sheen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

Thymosin ␣ 1 (T␣) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation. Ninety-eight patients with clinicopathologically proven chronic hepatitis B were randomly allocated to 3 groups: 1) group A received a 26-week course of T